I understand what you're saying and no I didn't expect it to be immune. What I didn't expect was for the management to put out a terrible scoping study after delaying it for so long. This stock is in free fall (like many others). The fact that we are 2.2c bid with no buyers in site, BP need the stock to go up 50% to breakeven after only getting shares a few weeks ago plus we're trading at $15m market cap which includes about $7m in cash speaks volumes. Basically, the market is giving no value to the 3bn tonnes of coal as it doesn't believe the story. This is management's issue. We need to see the game plan and hence why I have no faith in management. When they did a roadshow a few months ago, I found it strange that there was little buying afterwards. So yes, this is just my opinion, but the guy is a dud.
NMR Price at posting:
2.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)